Shenzhen Stock Exchange: Genscript Biotech (01672) and Xizhi Technology (01879) will be included as eligible stocks for the Hong Kong Stock Connect under the Shenzhen-Hong Kong Stock Connect.
According to the relevant provisions of the "Implementation Measures for Shenzhen-Hong Kong Stock Connect" by the Shenzhen Stock Exchange, the list of eligible securities for the Hong Kong Stock Connect will be adjusted and come into effect on September 7, 2026.
On September 7, the Shenzhen Stock Exchange announced that, in accordance with the relevant provisions of the "Implementation Measures for Shenzhen-Hong Kong Stock Connect," the list of eligible securities for the Hong Kong stock connect has been adjusted and will take effect from September 7, 2026. The new additions include Galactech Pharmaceuticals (01672), Xizhi Technology (01879), and Baidu Group (09888), while NISSIN FOODS (01475), HAICHANG HLDG (02255), and SYNAGISTICS (02562) will be removed.
Related Articles
XIAOMI-W (01810) spent HKD 9,968,600 to buy back 362,000 shares on September 7.
CINDA INTL HLDG (00111) purchases bonds and notes
NAYUKI (02150) spent HKD 1.504 million to repurchase 2.24 million shares on September 7.
XIAOMI-W (01810) spent HKD 9,968,600 to buy back 362,000 shares on September 7.
CINDA INTL HLDG (00111) purchases bonds and notes
NAYUKI (02150) spent HKD 1.504 million to repurchase 2.24 million shares on September 7.
RECOMMEND
